{"id":"5709d7c9-9b8a-5b86-9c7b-84706fb6b92a","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-ampk-activation","predicate":"activates","statement":"Metformin activated AMPK in hepatocytes, reducing acetyl-CoA carboxylase activity, inducing fatty acid oxidation and suppressing expression of lipogenic enzymes.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"a09df899-fd4c-54d8-97df-632dc03265d1","mechanism_event_label":"The cell reads the drug as an energy shortage and switches to burning rather than storing.","subject":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"object":{"id":"8128eec0-61cc-51ef-8d4e-5ec9678e8dfa","slug":"ampk-complexes","display_name":"AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"evidence_count":1,"mechanism_event":{"id":"a09df899-fd4c-54d8-97df-632dc03265d1","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-ampk-activation-event","event_type":"biochemical_relationship","label":"The cell reads the drug as an energy shortage and switches to burning rather than storing.","description":"Metformin activated AMPK in hepatocytes, reducing acetyl-CoA carboxylase activity, inducing fatty acid oxidation and suppressing expression of lipogenic enzymes.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"ae7b709a-c5e2-5814-af16-920bddacc7c7","slug":"acaca","display_name":"Human acetyl-CoA carboxylase 1 / ACACA","entity_type_key":"protein"},"role":"downstream_target","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"73cef62a-fc2e-5072-9fff-402e58d165fa","slug":"fatty-acid-oxidation","display_name":"Cellular fatty acid oxidation","entity_type_key":"cellular_process"},"role":"downstream_process","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"8128eec0-61cc-51ef-8d4e-5ec9678e8dfa","slug":"ampk-complexes","display_name":"AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/metformin-research/11602624.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\", \"start_char\": 0, \"end_char\": 1390, \"text_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Rat hepatocytes, isolated rat skeletal muscle and metformin-treated rats with an AMPK inhibitor","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Metformin in hepatocytes and in vivo; compound C AMPK inhibition","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The inhibitor experiment supports a requirement for AMPK in these hepatocytes; later work in AMPK-deficient mice reached a different conclusion, recorded separately.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"metformin","display_name":"Metformin","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The cell reads the drug as an energy shortage and switches to burning rather than storing.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[metformin-p11602624] Role of AMP-activated protein kinase in mechanism of metformin action. (2001). https://pubmed.ncbi.nlm.nih.gov/11602624/ DOI: 10.1172/jci13505","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Liver and skeletal muscle","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"55100797-9167-5ca4-9445-e690c0d755ff","evidence_kind":"source_excerpt","locator":"Lines 528-539","start_line":528,"end_line":539,"excerpt":"### metformin-ampk-activation\nMetformin activated AMPK in hepatocytes, reducing acetyl-CoA carboxylase activity, inducing fatty acid oxidation and suppressing expression of lipogenic enzymes.\nCondition category: normal\nnutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.\nplain_language: The cell reads the drug as an energy shortage and switches to burning rather than storing.\norganism: Rat\ntissue_or_cell_type: Liver and skeletal muscle\nexperimental_model: Rat hepatocytes, isolated rat skeletal muscle and metformin-treated rats with an AMPK inhibitor\nlimitations: The inhibitor experiment supports a requirement for AMPK in these hepatocytes; later work in AMPK-deficient mice reached a different conclusion, recorded separately.\nexposure: Metformin in hepatocytes and in vivo; compound C AMPK inhibition\nevidence_span: {\"source_cache\": \"artifacts/metformin-research/11602624.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\", \"start_char\": 0, \"end_char\": 1390, \"text_sha256\": \"86e283289def8a6e3e3098d49f321dbcca9a6cd4677ba84f26daf17467179237\"}\n[metformin-p11602624] Role of AMP-activated protein kinase in mechanism of metformin action. (2001). https://pubmed.ncbi.nlm.nih.gov/11602624/ DOI: 10.1172/jci13505","model_system":"Rat hepatocytes, isolated rat skeletal muscle and metformin-treated rats with an AMPK inhibitor","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [metformin-p11602624] Role of AMP-activated protein kinase in mechanism of metformin action. (2001). https://pubmed.ncbi.nlm.nih.gov/11602624/ DOI: 10.1172/jci13505","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d0474bd9-7cfd-5695-a152-12f3633a6813","stable_key":"import-8b3cf083-ea9c-54f5-b42b-bf1fef5b2978","title":"Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"0b51d0759aeeb88ac5b3a6277245a196b2bb024d7c32ec89379ed428fb06bfb5","revision_id":"0405c75e-f06e-5af7-a642-1777802f6004","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}